The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis

Chest

Volumn 132, Issue 1, 2007, Pages 231-237

  Riekert, Kristin A ^a   Bartlett, Susan J ^a   Boyle, Michael P ^a   Krishnan, Jerry A ^b   Rand, Cynthia S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adults; Cystic fibrosis; Depression; Health related quality of life; Lung function; Psychosocial; Pulmonary function test

Indexed keywords

ADULT; ARTICLE; CORRELATION FUNCTION; CYSTIC FIBROSIS; CYSTIC FIBROSIS QUESTIONNAIRE; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 34447519298     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2474     Document Type: Article

References (51)

1. Cystic Fibrosis Foundation. Patient registry: 2005 annual report. Bethesda, MD: Cystic Fibrosis Foundation, 2005
2. Britto MT, Kotagal UR, Hornung RW, et al. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002; 121:64-72
3. Gee L, Abbott J, Conway SP, et al. Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity. J Cyst Fibros 2003; 2:206-213
4. Staab D, Wenninger K, Gebert N, et al. Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? Thorax 1998; 53:727-731
5. Orenstein DM, Nixon PA, Ross EA, et al. The quality of well-being in cystic fibrosis. Chest 1989; 95:344-347
6. Quittner AL, Buu A, Messer MA, et al. Development and validation of the cystic fibrosis questionnaire in the united states: a health-related quality-of-life measure for cystic fibrosis. Chest 2005; 128:2347-2354
7. 1 in adults with cystic fibrosis. Pediatr Pulmonol 2004; 38:413-418
8. Anderson DL, Flume PA, Hardy KK. Psychological functioning of adults with cystic fibrosis. Chest 2001; 119:1079-1084
9. Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 2006; 130:1039-1047
10. Johnson EK, Jones JE, Seidenberg M, et al. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004; 45:544-550
11. Goldney RD, Phillips PJ, Fisher LJ, et al. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004; 27:1066-1070
12. Carels RA. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 2004; 13:63-72
13. Hajiro T, Nishimura K, Tsukino M, et al. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:785-790
14. Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006; 47:312-319
15. Lane D, Carroll D, Ring C, et al. Effects of depression and anxiety on mortality and quality-of-life 4 months after myocardial infarction. J Psychosom Res 2000; 49:229-238
16. Lane D, Carroll D, Ring C, et al. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63:221-230
17. Jackson JL, DeZee K, Berbano E. Can treating depression improve disease outcomes? Ann Intern Med 2004; 140:1054-1056
18. Matouk E, Ghezzo RH, Gruber J, et al. Internal consistency reliability and predictive validity of a modified N. Huang clinical scoring system in adult cystic fibrosis patients. Eur Respir J 1997; 10:2004-2013
19. Liou TG, Adler FR, FitzSimmons SC, et al. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153:345-352
20. Beck AT, Steer RA, Barbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988; 8:77-100
21. Quittner AL, Sweeny S, Watrous M, et al. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol 2000; 25:403-414
22. Lustman PJ, Clouse RE, Griffith LS, et al. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 1997; 59:24-31
23. Savard J, Laberge B, Gauthier JG, et al. Screening clinical depression in HIV-seropositive patients using the Hospital Anxiety and Depression Scale. AIDS Behav 1999; 3:167-175
24. Cavanaugh S, Clark DC, Gibbons RD. Diagnosing depression in the hospitalized medically ill. Psychosomatics 1983; 24:809-815
25. SPSS, Inc. Release 14.0.0: SPSS for Windows. Chicago, IL: SPSS Inc, 2005
26. Eisner MD, Katz PP, Lactao G, et al. Impact of depressive symptoms on adult asthma outcomes. Ann Allergy Asthma Immunol 2005; 94:566-574
27. Creed F, Morgan R, Fiddler M, et al. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 2002; 43:302-309
28. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107
29. Smith A, Krishnan JA, Bilderback A, et al. Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest 2006; 130:1034-1038
30. Almagro P, Calbo E, Ochoa de Echaguen, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448
31. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health 2004; 94:1133-1140
32. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28:1339-1345
33. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66:802-813
34. Sullivan MD, Levy WC, Crane BA, et al. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol 2004; 94:1577-1580
35. Himelhoch S, Weller WE, Wu AW, et al. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care 2004; 42:512-521
36. Arroll B, Macgillivray S, Ogston S, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med 2005; 3:449-456
37. Pampallona S, Bollini P, Tibaldi G, et al. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004; 61:714-719
38. Arnow BA, Constantino MJ. Effectiveness of psychotherapy and combination treatment for chronic depression. J Clin Psychol 2003; 59:893-905
39. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003; 289:3106-3116
40. Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1998; 129:613-621
41. Krishnan KR. Treatment of depression in the medically ill. J Clin Psychopharmacol 2005; 25(suppl):S14-S18
42. Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005; 62:792-798
43. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosom Med 2004; 66:466-474
44. Cheer SM, Goa KL. Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. Drugs 2001; 61:81-110
45. Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory II. San Antonio, TX: Psychological Corporation, 1996
46. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401
47. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-370
48. Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354:229-240
49. Clark MM, Niaura R, King TK, et al. Depression, smoking, activity level, and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav 1996; 21:509-513
50. Bech P, Lucas R, Amir M, et al. Association between clinically depressed subgroups, type of treatment and patient retention in the LIDO Study. Psychol Med 2003; 33:1051-1059
51. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 88:337-341